Last reviewed · How we verify

NCT07188649

Postoperative SpO₂/FiO₂ in Obese and Non-Obese Patients: Role of STOP-BANG

Not yet recruiting Last updated 23 September 2025
What this trial tests

trial testing oxygen deficiency in Oxygen Deficiency in 64 participants. Not yet recruiting.

Timeline
25 September 2025
Primary endpoint
25 January 2026
15 February 2026

Quick facts

Lead sponsorIstinye University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment64
Start date25 September 2025
Primary completion25 January 2026
Estimated completion15 February 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

18 and older, any sex, with Oxygen Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of the Reverse Trendelenburg position on oxygenation (SpO₂/FiO₂ ratio) in the early postoperative period in patients undergoing laparoscopic surgery. In our study, obesity is considered as a comparative subgroup in terms of variability of this effect; additionally, the STOP-BANG score, which measures the risk of obstructive sleep apnea syndrome, is examined as an auxiliary indicator.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oxygen Deficiency

Currently open trials in the same condition.

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07188649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing